ViewMind today announced Scarlett Sijia Chen, Managing Partner of Verge HealthTech Fund, has been elected to ViewMind’s board of directors. Scarlett brings decades of experience…
Highlights: • A biomarker to ‘prospectively’…
Oculomotor behaviors linked to cognitive performance revealed neurocognitive features of Alzheimer’s disease (AD) that can enhance the accuracy of its assessment and diagnosis
ViewMind is excited to announce the opening of ViewMind Labs at one of the most highly regarded centers of excellence globally for research and clinical…
ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders ViewMind Inc., the brain
ViewMind sets up for the next stage of growth with executive appointment.
ViewMind sets up for the next stage of growth with C-level and Director appointments.
ViewMind today announced Scarlett Sijia Chen, Managing Partner of Verge HealthTech Fund, has been elected to ViewMind’s board of directors. Scarlett brings decades of experience…
Highlights: • A biomarker to ‘prospectively’ predict Alzheimer’s Disease with high accuracy. PPV 94% and NPV 100% • Ability to very accurately differentiate cognitive decline…
Oculomotor behaviors linked to cognitive performance revealed neurocognitive features of Alzheimer’s disease (AD) that can enhance the accuracy of its assessment and diagnosis
ViewMind is excited to announce the opening of ViewMind Labs at one of the most highly regarded centers of excellence globally for research and clinical…
ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders Homepage >> Press Releases >> ViewMind announces
ViewMind Applauded by Frost & Sullivan for Its One-of-a-kind Digital Biomarker Technology for Neurocognitive Disorders Homepage >> Press Releases >> ViewMind Applauded by
Brain Health for Life
Easy to perform. Non-invasive.
Precision Neurology.
